Alnylam Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Alnylam Pharmaceuticals patents 222 in total
| Status | Patent |
|---|---|
Grant | Utility: Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression Filling date: 8 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Modified double-stranded RNA agents Filling date: 8 Sep 2025 Issue date: 30 Aug 2022 |
Grant | Utility: Angiotensinogen (AGT) iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 23 Aug 2022 |
Application | Utility: BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS Filling date: 8 Sep 2025 Issue date: 11 Aug 2022 |
Grant | Utility: Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 9 Aug 2022 |
Application | Utility: SERPIN FAMILY F MEMBER 2 (SERPINF2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: DUAL TARGETING siRNA AGENTS Filling date: 8 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: ORAL DELIVERY OF OLIGONUCLEOTIDES Filling date: 8 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: HIGH DENSITY LIPOPROTEIN BINDING PROTEIN (HDLBP/VIGILIN) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS Filling date: 8 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS Filling date: 8 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: ENDOSOMAL CLEAVABLE LINKERS Filling date: 8 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES Filling date: 8 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS Filling date: 8 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 21 Apr 2022 |
Grant | Utility: Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 19 Apr 2022 |
Application | Utility: BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS Filling date: 8 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: MULTI-TARGETED SINGLE ENTITY CONJUGATES Filling date: 8 Sep 2025 Issue date: 7 Apr 2022 |
Grant | Utility: Endosomal cleavable linkers Filling date: 8 Sep 2025 Issue date: 29 Mar 2022 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Mar 2022 |
Grant | Utility: Methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression Filling date: 8 Sep 2025 Issue date: 1 Mar 2022 |
Grant | Utility: Biodegradable lipids for the delivery of active agents Filling date: 8 Sep 2025 Issue date: 15 Feb 2022 |
Application | Utility: APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 3 Feb 2022 |
Grant | Utility: Serum amyloid P component (APCS) iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 25 Jan 2022 |
Application | Utility: MODIFIED DOUBLE-STRANDED RNA AGENTS Filling date: 8 Sep 2025 Issue date: 6 Jan 2022 |
Grant | Utility: Coronavirus iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: High density lipoprotein binding protein (Hdlbp/Vigilin) iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 28 Dec 2021 |
Application | Utility: COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE Filling date: 8 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF PROTEIN C (PROC) GENES Filling date: 8 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES Filling date: 8 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: MODIFIED DOUBLE STRANDED OLIGONUCLEOTIDE Filling date: 8 Sep 2025 Issue date: 16 Dec 2021 |
Grant | Utility: Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: Compositions and methods for inhibiting expression of TMPRSS6 gene Filling date: 8 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: Complement component iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 30 Nov 2021 |
Application | Utility: Compositions and Methods for Treating Transthyretin (TTR) Mediated Amyloidosis Filling date: 8 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE Filling date: 8 Sep 2025 Issue date: 11 Nov 2021 |
Grant | Utility: Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 2 Nov 2021 |
Grant | Utility: Complement component C5 iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 2 Nov 2021 |
Application | Utility: KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: HEPATITIS B VIRUS (HBV) dsRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 28 Oct 2021 |
Grant | Utility: Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 19 Oct 2021 |
Grant | Utility: Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene Filling date: 8 Sep 2025 Issue date: 19 Oct 2021 |
Grant | Utility: Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 12 Oct 2021 |
Showing 1 to 50 of 222 patents.